Search

everythinglearnresearchcommunity

for

Search:↓

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Platycladi Cacumen may help treat hair loss by affecting certain biological pathways.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Polydopamine and quercetin together can speed up hair regrowth.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

Valproic acid is an effective seizure medication with some temporary side effects.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Pranlukast and mirabegron may work as new diabetes drugs.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Caribine from traditional Chinese medicine may help treat hair loss.

Pioglitazone use was linked to hair regrowth in a patient with permanent hair loss from cicatricial alopecia.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The HDDPiW-jSB solution may prevent hair loss caused by docetaxel in rats when applied regularly.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.